Skip to Content

Iquix Dosage

Generic name: levofloxacin 15mg in 1mL
Dosage form: ophthalmic solution

Medically reviewed on March 19, 2018.

Days 1 through 3

Instill one to two drops in the affected eye(s) every 30 minutes to 2 hours while awake and approximately 4 and 6 hours after retiring.

Day 4 through treatment completion

Instill one to two drops in the affected eye(s) every 1 to 4 hours while awake.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Iquix (levofloxacin ophthalmic)

Consumer resources

Other brands: Quixin

Professional resources

Related treatment guides

Antibiotics 101

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Drug Class

Ophthalmic anti-infectives

Related Drugs

Conjunctivitis, Bacterial azithromycin ophthalmic, ciprofloxacin ophthalmic, levofloxacin ophthalmic, erythromycin ophthalmic, gentamicin ophthalmic, bacitracin ophthalmic, moxifloxacin ophthalmic, tobramycin ophthalmic, TobraDex, Polytrim, Vigamox, More...

Corneal Ulcer prednisone, diclofenac ophthalmic, ciprofloxacin ophthalmic, levofloxacin ophthalmic, Deltasone, Ocuflox, Ciloxan, Voltaren Ophthalmic, Sterapred DS, Sterapred, Prednicot, More...

Iquix Rating

No reviews - Add your review 10/10

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated Dec 6th, 2018), Cerner Multum™ (updated Dec 7th, 2018), Wolters Kluwer™ (updated Dec 5th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.